Home ETF List About

ETF Holdings Breakdown of VTRS

Stock NameViatris Inc
TickerVTRS(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS92556V1061
LEI254900ZZTSW7NL773X71

VTRS institutional holdings

The following institutional investment holdings of VTRS have been identified

Date ETF ISIN/Name Num Shares Book value
2025-09-18 IE00B5BMR087 (iShares Core S&P 500 UCITS ETF USD (Acc)) 2,821,801 0.0%USD 27,822,958 2.4%
2025-09-18 IE00BD8KRH84 (iShares Core S&P 500 UCITS ETF GBP Hedged (Dist)) 2,821,801 0.0%USD 27,822,958 2.4%
2025-09-18 IE00BL3J3G74 (iShares Core S&P 500 UCITS ETF MXN Hedged (Acc)) 2,821,801 0.0%USD 27,822,958 2.4%
2025-09-18 IE0031442068 (iShares Core S&P 500 UCITS ETF USD (Dist)) 418,304 0.0%USD 4,124,477 2.5%
2025-09-18 IE00B3ZW0K18 (iShares S&P 500 EUR Hedged UCITS ETF (Acc)) 204,765USD 1,714,490 3.0%
2025-09-18 IE0003WV2ME7 (iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc)) 991,507 0.1%USD 9,776,259 2.6%
2025-09-18 IE000MLMNYS0 (iShares S&P 500 Equal Weight UCITS ETF USD (Acc)) 991,507 0.1%USD 9,776,259 2.6%
2025-09-18 IE00B43HR379 (iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)) 565,653 0.1%USD 5,577,339 2.5%
2025-09-18 IE00BMBKBZ46 (iShares S&P 500 Health Care Sector UCITS ETF) 565,653 0.1%USD 5,577,339 2.5%
2025-09-18 IE00B3Y8X563 (iShares S&P 500 GBP Hedged UCITS ETF (Acc)) 27,670USD 201,303 3.2%
2025-09-18 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 690,934 0.3%USD 6,812,609 2.7%
2025-09-18 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 690,934 0.3%USD 6,812,609 2.7%
2025-09-18 IE000R9FA4A0 (iShares S&P 500 ESG UCITS ETF USD (Acc)) 21,874USD 215,678 2.4%
Total =13,634,204 USD 134,057,236
Book value of shares is calculated on the adjusted close price of each day (row).

News associated with VTRS

Notable ETF Inflow Detected - SPYD, CVS, VTRS, HPQ
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR Portfolio S&P 500 High Dividend ETF (Symbol: SPYD) where we have detected an approximate $224.1 million dollar inflow -- that's a 3.1% incre - 2025-09-05 11:52:24
Viatris: FDA Approves First Generic Iron Sucrose Injection
(RTTNews) - Viatris (VTRS) announced the FDA has approved Iron Sucrose Injection, USP, an intravenous iron replacement product used to treat iron deficiency anemia in adult and pediatric patients with chronic kidney disease. The FDA granted Viatris a competitive generic therapy d - 2025-08-11 10:43:53
Viatris Reports Positive Data From Presbyopia Study
(RTTNews) - Viatris Inc. (VTRS), Thursday announced positive top-line results from VEGA-3, evaluating MR-141 in patients with presbyopia, the progressive loss of the ability to focus on close objects. - 2025-06-26 08:50:42
Daily Dividend Report: NVDA,ALL,RY,TD,VTRS
NVIDIA will pay its next quarterly cash dividend of $0.01 per share on April 2, 2025, to all shareholders of record on March 12, 2025. Allstate announced that its board of directors approved a quarterly common stock dividend of $1.00 on Feb. 26, 2025, which is an increase of $0 - 2025-02-27 15:01:58
After Hours Most Active for Jan 31, 2025 : NVDA, VTRS, GRAB, AAPL, VZ, HRL, WBD, DOC, IP, ES, GOOGL, KIM
The NASDAQ 100 After Hours Indicator is down -17.78 to 21,460.27. The total After hours volume is currently 176,419,368 shares traded.The following are the most active stocks for the after hours session: NVIDIA Corporation (NVDA) is +0.2393 at $120.31, with 11,968,760 shares tra - 2025-01-31 19:24:54

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.